VEGFA and glioblastoma: Because losartan and other ARBs have been shown to lower vascular endothelial growth factor (VEGF) expression in GBM models and vasogenic edema in retrospective patient studies (3, –5), we decided to test the effects of losartan treatment on ICB-induced edema.